|
AMLX
|
Amylyx Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
AQST
|
Aquestive Therapeutics, Inc.
|
US
|
NASDAQ
|
|
BCLI
|
Brainstorm Cell Therapeutics Inc.
|
US
|
NASDAQ
|
|
COYA
|
Coya Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CYTK
|
Cytokinetics, Incorporated
|
US
|
NASDAQ
|
|
DNLI
|
Denali Therapeutics Inc.
|
US
|
NASDAQ
|
|
LBPH
|
Longboard Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
MITO
|
Stealth BioTherapeutics Corp.
|
US
|
NASDAQ
|
|
MYO
|
Myomo Inc.
|
US
|
AMEX
|
|
PMN
|
ProMIS Neurosciences Inc.
|
US
|
NASDAQ
|
|
PRTA
|
Prothena Corporation plc
|
US
|
NASDAQ
|
|
SNPX
|
Synaptogenix, Inc.
|
US
|
NASDAQ
|
|
VYGR
|
Voyager Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ABSCF
|
Ab Science Paris
|
US
|
OTC
|
|
ACOGF
|
Alpha Cognition Inc
|
US
|
OTC
|
|
BIEI
|
Premier Biomedical
|
US
|
OTC
|
|
NURPF
|
Neuren Pharmaceutica
|
US
|
OTC
|
|
OZYMF
|
Orphazyme A S
|
US
|
OTC
|
|
ACOG
|
Alpha Cognition Inc
|
CA
|
TSXV
|
|
PMN
|
ProMIS Neurosciences Inc.
|
CA
|
TSX
|